BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22999413)

  • 1. Norethisterone acetate alters coagulation gene expression in vitro in human cell culture.
    Brosnan JF; Sheppard BL; Kelly LA; O'Leary JJ; Norris LA
    Thromb Res; 2013 Jan; 131(1):72-7. PubMed ID: 22999413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens.
    Kelly LA; O'Leary JJ; Seidlova-Wuttke D; Wuttke W; Norris LA
    Thromb Haemost; 2010 Dec; 104(6):1250-7. PubMed ID: 20838740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor alpha augments changes in hemostatic gene expression in HepG2 cells treated with estradiol and phytoestrogens.
    Kelly LA; Seidlova-Wuttke D; Wuttke W; O'Leary JJ; Norris LA
    Phytomedicine; 2014 Jan; 21(2):155-8. PubMed ID: 23972791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
    Brosnan JF; Sheppard BL; Norris LA
    Thromb Haemost; 2007 Apr; 97(4):558-65. PubMed ID: 17393018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1.
    Borgfeldt C; Li C; Samsioe G
    Climacteric; 2004 Mar; 7(1):78-85. PubMed ID: 15259286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells.
    Nishimura H; Tsuji H; Masuda H; Kasahara T; Yoshizumi M; Sugano T; Kimura S; Kawano H; Kunieda Y; Yano S; Nakagawa K; Kitamura H; Nakahara Y; Sawada S; Nakagawa M
    Thromb Haemost; 1999 Nov; 82(5):1516-21. PubMed ID: 10595647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
    Shirk RA; Zhang Z; Winneker RC
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):361-8. PubMed ID: 15857755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
    Dahm AE; Eilertsen AL; Goeman J; Olstad OK; Ovstebø R; Kierulf P; Mowinckel MC; Skretting G; Sandset PM
    Thromb Res; 2012 Jul; 130(1):45-51. PubMed ID: 22217510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin affects tissue plasminogen activator and plasminogen activator inhibitor I expression: a potential prothrombotic mechanism of drug-eluting stents.
    Ma Q; Zhou Y; Nie X; Yu M; Gao F; Wang Z; Ge H; Jia D; Yang S; Liu X; Han H; Hu B; Shen H; Xu X
    Angiology; 2012 Jul; 63(5):330-5. PubMed ID: 21900343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
    Cao YJ; Wu YH; Liu CF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):62-7. PubMed ID: 19099932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1).
    Gopal S; Garibaldi S; Goglia L; Polak K; Palla G; Spina S; Genazzani AR; Genazzani AD; Simoncini T
    Mol Hum Reprod; 2012 Aug; 18(8):410-6. PubMed ID: 22389473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homocysteine' s effect on tPA and PAI-1 gene expression in HUVEC].
    Zhou LJ; Mei YF; Wang LF; Jin H; Li SJ; Yin XS; Li WM
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2004 Nov; 20(4):363-6. PubMed ID: 21158116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effects.
    Schatz F; Kuczynski E; Kloosterboer HJ; Buchwalder L; Tang C; Krikun G; Lockwood CJ
    Steroids; 2005 Nov; 70(12):840-5. PubMed ID: 16011840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells.
    Jin H; Lin J; Fu L; Mei YF; Peng G; Tan X; Wang DM; Wang W; Li YG
    Biochem Cell Biol; 2007 Apr; 85(2):246-51. PubMed ID: 17534406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium.
    Grabowski EF; Kushak RI; Liu B; Ingelfinger JR
    Thromb Res; 2013 Jun; 131(6):521-8. PubMed ID: 23642803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery.
    Payeli SK; Latini R; Gebhard C; Patrignani A; Wagner U; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):705-10. PubMed ID: 18258816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of norethisterone acetate on estrogen metabolism in postmenopausal women.
    Seeger H; Mueck AO; Lippert TH
    Horm Metab Res; 2000 Oct; 32(10):436-9. PubMed ID: 11069210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
    Panay N; Ylikorkala O; Archer DF; Gut R; Lang E
    Climacteric; 2007 Apr; 10(2):120-31. PubMed ID: 17453860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.